Classification
- Anatomical main groupBBlood and blood-forming organs
- Therapeutic subgroupB01
- Pharmacological subgroupB01A
- Chemical subgroupB01AE
- Chemical substanceB01AE06Bivalirudin
Where it is registered
Each register with its number of medicines and a few of them.
Canada
Health Canada · 7 medicines
- Angiomax250 MG / VIAL · Powder For Solution · Sandoz Canada Incorporated
- Bivalirudin for Injection250 MG / VIAL · Powder For Solution · Juno Pharmaceuticals Corp.
- Bivalirudin for Injection250 MG / VIAL · Powder For Solution · Formative Pharma INC.
- Bivalirudin for Injection250 MG / VIAL · Powder For Solution · Fresenius Kabi Canada LTD
United States
FDA · 5 medicines



